Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turetschek, K.
Right arrow Articles by Brasch, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turetschek, K.
Right arrow Articles by Brasch, R. C.
(Radiology. 2001;218:562-569.)
© RSNA, 2001


Experimental Studies

MR Imaging Characterization of Microvessels in Experimental Breast Tumors by Using a Particulate Contrast Agent with Histopathologic Correlation1

Karl Turetschek, MD, Sabine Huber, MD, Eugenia Floyd, DVM, Thomas Helbich, MD, Timothy P. L. Roberts, PhD, David M. Shames, MD, Kirk S. Tarlo, PhD, Michael F. Wendland, PhD and Robert C. Brasch, MD

1 From the Center for Pharmaceutical and Molecular Imaging, Department of Radiology, University of California, San Francisco, Box 0628, 505 Parnassus Ave, San Francisco, CA 94143-0628 (K.T., S.H., T.H., T.P.L.R., D.M.S., M.F.W., R.C.B.); Dept of Radiology, Univ of Vienna, Austria (K.T., T.H.); Dept of Radiology, KH Lainz, Vienna, Austria (S.H.); Dept of Pathology, Pfizer Central Research, Groton, Conn (E.F.); and Nycomed Amersham Imaging, Wayne, Pa (K.S.T.). Received Feb 3, 2000; revision requested Mar 21; final revision received Jun 22; accepted Jun 28. Supported by NIH grant RO1 CA82923-01 and the Cancer Research Fund, State of Calif, interagency agreement #97-12013 with Dept of Health Services, Cancer Research Program. K.T. supported by a grant from the Max Kade Foundation. Address correspondence to R.C.B.

PURPOSE: To define the diagnostic potential of magnetic resonance (MR) imaging enhanced with ultrasmall superparamagnetic iron oxide (USPIO) particles for the quantitative characterization of tumor microvasculature.

MATERIALS AND METHODS: NC100150 injection, a USPIO in clinical trials, and albumin-(Gd-DTPA)30 were compared at MR imaging on sequential days in the same 19 rats with mammary tumors. Kinetic analysis of dynamic T1-weighted three-dimensional spoiled gradient-recalled imaging data with a two-compartment bidirectional model yielded MR imaging estimates of microvascular permeability (KPS) and fractional plasma volume (fPV) for each contrast medium.

RESULTS: Strongly positive and significant correlations were observed between MR imaging–derived KPS estimates and histologic tumor grade with either the soluble albumin-(Gd-DTPA)30 (r = 0.88; P < .001) or larger particulate USPIO (r = 0.82; P < .001). A significant correlation (P < .05) was observed with each contrast medium between KPS and the histologic microvascular density (MVD), an angiogenesis indicator. Despite the considerable difference in molecule and particle sizes, no significant difference was observed in the MR imaging–derived mean permeability values generated with the two contrast media.

CONCLUSION: USPIO, a macromolecular particulate MR imaging contrast agent, can be applied successfully to characterize tumor microvessels in animals. USPIO-derived KPS correlated strongly with histopathologic tumor grade, MVD, and KPS values derived by using albumin-(Gd-DTPA)30 in the same tumors.

Index terms: Animals • Breast neoplasms, 00.30 • Contrast media • Iron • Magnetic resonance (MR), three-dimensional, 00.121411, 00.121412, 00.121419




This article has been cited by other articles:


Home page
RadiologyHome page
T. Persigehl, R. Bieker, L. Matuszewski, A. Wall, T. Kessler, H. Kooijman, N. Meier, W. Ebert, W. E. Berdel, W. Heindel, et al.
Antiangiogenic Tumor Treatment: Early Noninvasive Monitoring with USPIO-enhanced MR Imaging in Mice
Radiology, August 1, 2007; 244(2): 449 - 456.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
L. Matuszewski, T. Persigehl, A. Wall, N. Meier, R. Bieker, H. Kooijman, B. Tombach, R. Mesters, W. E. Berdel, W. Heindel, et al.
Assessment of Bone Marrow Angiogenesis in Patients with Acute Myeloid Leukemia by Using Contrast-enhanced MR Imaging with Clinically Approved Iron Oxides: Initial Experience
Radiology, December 1, 2006; 242(1): 217 - 224.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. R. Moreno, K-R. Purushothaman, M. Sirol, A. P. Levy, and V. Fuster
Neovascularization in Human Atherosclerosis
Circulation, May 9, 2006; 113(18): 2245 - 2252.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. Workman, E. O. Aboagye, Y.-L. Chung, J. R. Griffiths, R. Hart, M. O. Leach, R. J. Maxwell, P. M. J. McSheehy, P. M. Price, and J. Zweit
Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies.
J Natl Cancer Inst, May 3, 2006; 98(9): 580 - 598.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. Marzola, A. Degrassi, L. Calderan, P. Farace, E. Nicolato, C. Crescimanno, M. Sandri, A. Giusti, E. Pesenti, A. Terron, et al.
Early Antiangiogenic Activity of SU11248 Evaluated In vivo by Dynamic Contrast-Enhanced Magnetic Resonance Imaging in an Experimental Model of Colon Carcinoma
Clin. Cancer Res., August 15, 2005; 11(16): 5827 - 5832.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
J. S. Abramowicz
Ultrasonographic Contrast Media: Has the Time Come in Obstetrics and Gynecology?
J. Ultrasound Med., April 1, 2005; 24(4): 517 - 531.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
Q. G. de Lussanet, S. Langereis, R. G. H. Beets-Tan, M. H. P. van Genderen, A. W. Griffioen, J. M. A. van Engelshoven, and W. H. Backes
Dynamic Contrast-enhanced MR Imaging Kinetic Parameters and Molecular Weight of Dendritic Contrast Agents in Tumor Angiogenesis in Mice
Radiology, April 1, 2005; 235(1): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. C. Miller, H. H. Pien, D. Sahani, A. G. Sorensen, and J. H. Thrall
Imaging Angiogenesis: Applications and Potential for Drug Development
J Natl Cancer Inst, February 2, 2005; 97(3): 172 - 187.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. Kitagawa, H. Sakuma, N. Ishida, T. Hirano, A. Ishihara, and K. Takeda
Contrast-Enhanced High-Resolution MRI of Invasive Breast Cancer: Correlation with Histopathologic Subtypes
Am. J. Roentgenol., December 1, 2004; 183(6): 1805 - 1809.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
L. H. Dennis Cheong, C. C. Tchoyoson Lim, and T. S. Koh
Dynamic Contrast-enhanced CT of Intracranial Meningioma: Comparison of Distributed and Compartmental Tracer Kinetic Models--Initial Results
Radiology, September 1, 2004; 232(3): 921 - 930.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
A R Padhani
MRI for assessing antivascular cancer treatments
Br. J. Radiol., December 1, 2003; 76(suppl_1): S60 - S80.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
H. E. Daldrup-Link, J. Rydland, T. H. Helbich, A. Bjornerud, K. Turetschek, K. A. Kvistad, E. Kaindl, T. M. Link, K. Staudacher, D. Shames, et al.
Quantification of Breast Tumor Microvascular Permeability with Feruglose-enhanced MR Imaging: Initial Phase II Multicenter Trial
Radiology, December 1, 2003; 229(3): 885 - 892.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
B M Seddon and P Workman
The role of functional and molecular imaging in cancer drug discovery and development
Br. J. Radiol., December 1, 2003; 76(suppl_2): S128 - S138.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
Q. G. de Lussanet, W. H. Backes, A. W. Griffioen, J. M. A. van Engelshoven, and R. G. H. Beets-Tan
Gadopentetate Dimeglumine versus Ultrasmall Superparamagnetic Iron Oxide for Dynamic Contrast-enhanced MR Imaging of Tumor Angiogenesis in Human Colon Carcinoma in Mice
Radiology, November 1, 2003; 229(2): 429 - 438.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Kostourou, S. P. Robinson, G. St. J. Whitley, and J. R. Griffiths
Effects of Overexpression of Dimethylarginine Dimethylaminohydrolase on Tumor Angiogenesis Assessed by Susceptibility Magnetic Resonance Imaging
Cancer Res., August 15, 2003; 63(16): 4960 - 4966.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
G. A. Krombach, M. F. Wendland, C. B. Higgins, and M. Saeed
MR Imaging of Spatial Extent of Microvascular Injury in Reperfused Ischemically Injured Rat Myocardium: Value of Blood Pool Ultrasmall Superparamagnetic Particles of Iron Oxide
Radiology, November 1, 2002; 225(2): 479 - 486.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S. C. A. Michel, T. M. Keller, J. M. Frohlich, D. Fink, R. Caduff, B. Seifert, B. Marincek, and R. A. Kubik-Huch
Preoperative Breast Cancer Staging: MR Imaging of the Axilla with Ultrasmall Superparamagnetic Iron Oxide Enhancement
Radiology, November 1, 2002; 225(2): 527 - 536.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. M. McDonald and P. Baluk
Significance of Blood Vessel Leakiness in Cancer
Cancer Res., September 15, 2002; 62(18): 5381 - 5385.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
E. Fosslien
Molecular Pathology of Cyclooxygenase-2 in Cancer-induced Angiogenesis
Ann. Clin. Lab. Sci., October 1, 2001; 31(4): 325 - 348.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2001 by the Radiological Society of North America.